Hayden Jit Hei Cheung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hayden Jit Hei Cheung has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Chi-Leung Chiang
Department of Clinical Oncology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
1 shared publication- Haitao Li
Tsinghua University
1 shared publication - Jason Wing Hon Wong
The University of Hong Kong
1 shared publication Jinzhao Liu
State Key Laboratory of Pharmaceutical Biotechnology & Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China
1 shared publication- Kwan Yuen Wong
Department of Chemistry, The University of Hong Kong, Hong Kong, China
1 shared publication Mu He
School of Biomedical Sciences, The University of Hong Kong, Hong Kong, China
1 shared publication
Latest Publications
- 9 January 2026
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (3) , 471-481
Complex-specific inhibitors for interrogating ATAC histone acetyltransferase complex
Histone acetyltransferases (HATs) modify chromatin to regulate gene expression. Instead of acting alone, HATs function in complexes with other proteins, leading to variations in substrate specificity, genomic localization and cellular function. To understand the complex-dependent roles of HATs, we present a chemical approach to specifically dissociate ATAC (Ada-two-A-containing) HAT complex from chromatin without perturbing other complexes. Rather than targeting the shared HAT enzyme, we developed chemical inhibitors for an ATAC-specific subunit, YEATS2. The most effective inhibitor, LS-170, specifically reduced the chromatin occupancy of the ATAC complex, decreased the ATAC-dependent histone acetylation level and downregulated the expression of ATAC-governed genes, leading to significantly suppressed tumor growth in a lung cancer mouse model. This study not only sheds light on the regulatory roles of the ATAC HAT complex in gene transcription but also provides evidence that the chemical inhibition of the ATAC complex can be a promising therapeutic strategy.
- 9 January 2026
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (3) , 471-481
Complex-specific inhibitors for interrogating ATAC histone acetyltransferase complex
Histone acetyltransferases (HATs) modify chromatin to regulate gene expression. Instead of acting alone, HATs function in complexes with other proteins, leading to variations in substrate specificity, genomic localization and cellular function. To understand the complex-dependent roles of HATs, we present a chemical approach to specifically dissociate ATAC (Ada-two-A-containing) HAT complex from chromatin without perturbing other complexes. Rather than targeting the shared HAT enzyme, we developed chemical inhibitors for an ATAC-specific subunit, YEATS2. The most effective inhibitor, LS-170, specifically reduced the chromatin occupancy of the ATAC complex, decreased the ATAC-dependent histone acetylation level and downregulated the expression of ATAC-governed genes, leading to significantly suppressed tumor growth in a lung cancer mouse model. This study not only sheds light on the regulatory roles of the ATAC HAT complex in gene transcription but also provides evidence that the chemical inhibition of the ATAC complex can be a promising therapeutic strategy.